Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FL
1601
PUT
DELISTED
Foot Locker
FL
| $6.87M | 0.01% |
91,800
-38,300
| -29% | -$2.76M |
2013 Q2
15 quarters
|
|
|
BPMC
1602
DELISTED
Blueprint Medicines
BPMC
| $6.86M | 0.01% |
171,574
+96,863
| +130% | +$3.47M |
2016 Q3
2 quarters
|
|
1603
PUT
Range Resources
RRC
$8.93B
| $6.86M | 0.01% |
235,600
-60,300
| -20% | -$1.86M |
2013 Q2
15 quarters
|
|
1604
Brown-Forman Class B
BF.B
$12B
| $6.84M | 0.01% |
+231,602
| New | +$6.89M |
2017 Q1
0 quarters
|
|
|
EA
1605
PUT
DELISTED
Electronic Arts
EA
| $6.83M | 0.01% |
76,300
-213,100
| -74% | -$18.1M |
2013 Q2
15 quarters
|
|
1606
CALL
Ciena
CIEN
$55.5B
| $6.81M | 0.01% |
288,500
-111,900
| -28% | -$2.74M |
2013 Q2
15 quarters
|
|
|
LJPC
1607
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $6.81M | 0.01% |
+228,080
| New | +$5.82M |
2017 Q1
0 quarters
|
|
|
ACOR
1608
DELISTED
Acorda Therapeutics
ACOR
| $6.8M | 0.01% |
2,700
+2,374
| +728% | +$6.83M |
2015 Q3
6 quarters
|
|
|
UMPQ
1609
DELISTED
Umpqua Holdings Corp
UMPQ
| $6.8M | 0.01% |
383,472
+245,609
| +178% | +$4.51M |
2013 Q2
15 quarters
|
|
1610
PUT
Motorola Solutions
MSI
$74B
| $6.79M | 0.01% |
78,800
-121,300
| -61% | -$9.91M |
2013 Q2
15 quarters
|
|
1611
PUT
Howmet Aerospace
HWM
$92.2B
| $6.79M | 0.01% |
336,171
+43,032
| +15% | +$845K |
2016 Q4
1 quarter
|
|
|
ALXN
1612
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $6.79M | 0.01% |
56,000
-37,900
| -40% | -$4.89M |
2013 Q2
15 quarters
|
|
1613
iShares US Aerospace & Defense ETF
ITA
$12.2B
| $6.79M | 0.01% |
+91,292
| New | +$6.71M |
2017 Q1
0 quarters
|
|
1614
iShares S&P Small-Cap 600 Value ETF
IJS
$7.75B
| $6.79M | 0.01% |
97,906
+7,336
| +8% | +$511K |
2016 Q4
1 quarter
|
|
|
SLCA
1615
PUT
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $6.78M | 0.01% |
141,300
+5,100
| +4% | +$273K |
2013 Q2
15 quarters
|
|
|
ARRS
1616
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $6.78M | 0.01% |
256,369
-671,116
| -72% | -$18.8M |
2013 Q2
15 quarters
|
|
|
ZYNE
1617
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $6.77M | 0.01% |
+336,627
| New | +$6.69M |
2017 Q1
0 quarters
|
|
1618
CALL
Lennar Class A
LEN
$19.2B
| $6.76M | 0.01% |
138,779
-66,921
| -33% | -$3.03M |
2013 Q2
15 quarters
|
|
|
FM
1619
DELISTED
iShares Frontier and Select EM ETF
FM
| $6.76M | 0.01% |
243,764
+220,252
| +937% | +$6.05M |
2016 Q4
1 quarter
|
|
1620
CALL
Cboe Global Markets
CBOE
$28.3B
| $6.76M | 0.01% |
83,400
-40,700
| -33% | -$3.18M |
2013 Q2
15 quarters
|
|
|
AEL
1621
DELISTED
American Equity Investment Life Holding Company
AEL
| $6.76M | 0.01% |
286,037
+119,934
| +72% | +$2.98M |
2013 Q2
15 quarters
|
|
1622
CALL
Direxion Daily Small Cap Bear 3x ETF
TZA
$228M
| $6.75M | 0.01% |
936
-359
| -28% | -$2.7M |
2016 Q3
2 quarters
|
|
1623
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.4B
| $6.74M | 0.01% |
123,690
+114,708
| +1,277% | +$6.23M |
2016 Q4
1 quarter
|
|
1624
Shake Shack
SHAK
$2.46B
| $6.73M | 0.01% |
201,632
-62,642
| -24% | -$2.17M |
2015 Q2
7 quarters
|
|
1625
PUT
Diamondback Energy
FANG
$51.7B
| $6.73M | 0.01% |
64,900
+13,600
| +27% | +$1.4M |
2013 Q3
14 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.